Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia

Status unconfirmed · Phase 1

Conditions studied: Fanconi's Anemia

In brief

OBJECTIVES: I. Evaluate the toxicity of amifostine in patients with bone marrow failure related to Fanconi's anemia. II. Determine the efficacy of this treatment regimen in this patient population. III. Evaluate the effect of this treatment regimen on bone marrow progenitor cell proliferation and peripheral blood mononuclear cell apoptosis in these patients.

Key facts

Study ID
NCT00006127
Run by
Dana-Farber Cancer Institute
People needed
21
Starts
2000-04-01
Last updated by the study team
2005-06-24

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.